As a result of the growing demand for generic medicines and biologics, the capital-intensive nature of the business, and the complex manufacturing requirements, many pharmaceutical companies have identified the potential profitability in contracting with a CMO (contract manufacturing outsourcing) for both clinical and commercial stage manufacturing.  Additionally, pharmaceutical companies have been directing their priorities toward the core areas of competency, and hence, prefer not to dispense available resources, expertise, and technology on formulating the final dose of medicines.

1. Introduction 
 


2. Research Methodology 
 


3. Market Analysis 


4. Market Dynamics 

5. Technology Snapshot 

6. Segmentation - By Type 

7. Segmentation - By Region (Separate breakdown provided by API, FDF and Packaging for all the regions listed below) 

8. Competitive Landscape (Vendor Market Share Analysis) 


9. Competitive Intelligence – Key Vendor Profiles 

10. Investment Analysis 

11. Future of the Market